sa.vogel
TL2 · Nijmegen
Contributes reviews on supplier material. Based in Nijmegen.
Joined 25 November 2024 · last posted 1d
92Posts here
1Topics
4Solutions
1.1kLikes received
1.7kLikes given
24Badges
220Days visited
4.5kPosts read
Most-liked posts
-
Type 1 diabetes: off-label use and the evidence gap Started this topic · Clinical › Special populations · 5 Jul 2026 · 41 likes On the subject in the title: Type 1 diabetes: off-label use and the evidence gap Working notes rather than a conclusion. Type 1 diabetes, and specifically the version…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #44 · Compounds › Secretagogues & GH axis · 14 Jul 2026 · 32 likes Sermorelin and the growth hormone releasing hormone analogues depend on a functioning pituitary response, which is the mechanistic reason they behave differently in…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #37 · Compounds › Tirzepatide · 15 Nov 2024 · 31 likes Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak. Different populations, different durations, different…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #40 · Compounds › Repair & healing peptides · 11 Jun 2026 · 30 likes Reporting rather than recommending, on absence of controlled human data. What happened is above. Whether it should have is a different question and not one I am…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #56 · Practice › Interactions · 24 Nov 2025 · 29 likes Post #53 is the version of this I will quote in future. One addition. I keep a log for Warfarin and altered intake specifically because my memory of it turned out to be…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #139 · Compounds › Tirzepatide · 17 Jul 2025 · 28 likes SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed diabetes dose at the time and it was not the highest dose available in…
Where this member posts
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| First Reply | bronze | 26 Nov 2024 |
| Basic User | bronze | 28 Nov 2024 |
| Read the Guidelines | bronze | 28 Nov 2024 |
| First Link | bronze | 30 Nov 2024 |
| First Topic | bronze | 8 Dec 2024 |
| Member | bronze | 11 Dec 2024 |
| Welcome | bronze | 13 Dec 2024 |
| First Quote | bronze | 26 Dec 2024 |
| Asked Well | bronze | 29 Dec 2024 |
| First Solution | bronze | 5 Jan 2025 |
| First Tag | bronze | 19 Jan 2025 |
| Editor | bronze | 20 Jan 2025 |
| Consistently Generous | silver | 4 Feb 2025 |
| Generous | bronze | 15 Feb 2025 |
| Reader | bronze | 26 Feb 2025 |
| Popular Link | silver | 26 Mar 2025 |
| Sourced | bronze | 11 Apr 2025 |
| Good Post | silver | 22 Apr 2025 |
| Nice Topic | bronze | 23 Apr 2025 |
| Nice Post | bronze | 25 Apr 2025 |
| Thank You | silver | 25 May 2025 |
| Good Topic | silver | 31 May 2025 |
| Answered Well | silver | 21 Oct 2025 |
| Anniversary | silver | 25 Nov 2025 |